Baixe o app para aproveitar ainda mais
Prévia do material em texto
18/03/20 1 Patologia Conteúdo: § Resposta celular § Adaptação celular § Lesão celular § Morte celular Profa. Dra. Daiani Cristina Cilião Alves Haddad Ní ve ld e ad ve rs id ad e da s c on di çõ es (n ív el de st re ss ce lu la r, gr av id ad e da in jú ria ) Homeostase – Função celular normal Adaptação/alteração celular fisiológica ou patológica, pequena injúria reversível -‐ Função celular pouco comprometida. Injúria irreversível, morte celular – Função celular ausente. Fontes de stress celular: isquemia, infecção, toxinas, resposta imune, etc. PATOLOGIA – Resposta celular PATOLOGIA – Resposta celular Estágios na resposta celular ao estresse e estímulos nocivos. PATOLOGIA – Adaptação celular Hipertrofia e ñ atividade funcional Hiperplasia Atrofia Metaplasia Fisiológica Patológica Células musculares lisas do útero durante a gravidez; Cardiomiócitos em quadro de Hipertensão. Hipertrofia: 3Cellular Adaptations to Stress cells have a limited capacity to divide. Hypertrophy and hyperplasia also can occur together, and obviously both result in an enlarged (hypertrophic) organ. Hypertrophy can be physiologic or pathologic and is caused either by increased functional demand or by growth factor or hormonal stimulation. • The massive physiologic enlargement of the uterus during pregnancy occurs as a consequence of estrogen- stimulated smooth muscle hypertrophy and smooth muscle hyperplasia (Fig. 1–3). In contrast, in response to increased demand the striated muscle cells in both the skeletal muscle and the heart can undergo only hyper- trophy because adult muscle cells have a limited capac- ity to divide. Therefore, the chiseled physique of the avid weightlifter stems solely from the hypertrophy of individual skeletal muscles. • An example of pathologic cellular hypertrophy is the cardiac enlargement that occurs with hypertension or aortic valve disease (Fig. 1–2). The mechanisms driving cardiac hypertrophy involve at least two types of signals: mechanical triggers, such as stretch, and trophic triggers, which typically are soluble mediators that stimulate cell growth, such as growth factors and adrenergic hormones. These stimuli turn on signal transduction pathways that lead to the induction of a number of genes, which in turn stimulate synthesis of many cellular proteins, including growth factors and struc- tural proteins. The result is the synthesis of more proteins and myofilaments per cell, which increases the force gener- ated with each contraction, enabling the cell to meet increased work demands. There may also be a switch of contractile proteins from adult to fetal or neonatal forms. For example, during muscle hypertrophy, the α-myosin heavy chain is replaced by the β form of the myosin heavy chain, which produces slower, more energetically econom- ical contraction. Whatever the exact mechanisms of hypertrophy, a limit is reached beyond which the enlargement of muscle mass clinical impact. Whether a specific form of stress induces adaptation or causes reversible or irreversible injury depends not only on the nature and severity of the stress but also on several other variables, including basal cellular metabolism and blood and nutrient supply. In this chapter we discuss first how cells adapt to stresses and then the causes, mechanisms, and consequences of the various forms of acute cell damage, including reversible cell injury, subcellular alterations, and cell death. We con- clude with three other processes that affect cells and tissues: intracellular accumulations, pathologic calcification, and cell aging. CELLULAR ADAPTATIONS TO STRESS Adaptations are reversible changes in the number, size, phenotype, metabolic activity, or functions of cells in response to changes in their environment. Physiologic adap- tations usually represent responses of cells to normal stimu- lation by hormones or endogenous chemical mediators (e.g., the hormone-induced enlargement of the breast and uterus during pregnancy). Pathologic adaptations are responses to stress that allow cells to modulate their struc- ture and function and thus escape injury. Such adaptations can take several distinct forms. Hypertrophy Hypertrophy is an increase in the size of cells resulting in increase in the size of the organ. In contrast, hyperplasia (dis- cussed next) is characterized by an increase in cell number because of proliferation of differentiated cells and replace- ment by tissue stem cells. Stated another way, in pure hypertrophy there are no new cells, just bigger cells containing increased amounts of structural proteins and organelles. Hyperplasia is an adaptive response in cells capable of replication, whereas hypertrophy occurs when Figure 1–3 Physiologic hypertrophy of the uterus during pregnancy. A, Gross appearance of a normal uterus (right) and a gravid uterus (left) that was removed for postpartum bleeding. B, Small spindle-shaped uterine smooth muscle cells from a normal uterus. C, Large, plump hypertrophied smooth muscle cells from a gravid uterus; compare with B. (B and C, Same magnification.) A B C C H A P T E R 1 Cell Injury, Cell Death, and Adaptations2 Figure 1–1 Stages in the cellular response to stress and injurious stimuli. NORMAL CELL (homeostasis) ADAPTATION Stress Inability to adapt CELL INJURY Injurious stimulus Mild, transient Severe, progressive REVERSIBLE INJURY IRREVERSIBLE INJURY CELL DEATHNECROSIS APOPTOSIS Figure 1–2 The relationship among normal, adapted, reversibly injured, and dead myocardial cells. The cellular adaptation depicted here is hypertrophy, the type of reversible injury is ischemia, and the irreversible injury is ischemic coagulative necrosis. In the example of myocardial hypertrophy (lower left), the left ventricular wall is thicker than 2 cm (normal, 1–1.5 cm). Reversibly injured myocardium shows functional effects without any gross or light microscopic changes, or reversible changes like cellular swelling and fatty change (shown here). In the specimen showing necrosis (lower right) the trans- mural light area in the posterolateral left ventricle represents an acute myocardial infarction. All three transverse sections of myocardium have been stained with triphenyltetrazolium chloride, an enzyme substrate that colors viable myocardium magenta. Failure to stain is due to enzyme loss after cell death. Cell death Reversibly injured myocyte Cell injury Normal myocyte Adapted myocyte (hypertrophy) Adaptation: response to increased load adaptation, achieving a new steady state and preserving viability and function. The principal adaptive responses are hypertrophy, hyperplasia, atrophy, and metaplasia. If the adaptive capability is exceeded or if the external stress is inherently harmful, cell injury develops (Fig. 1–1). Within certain limits, injury is reversible, and cells return to a stable baseline; however, if the stress is severe, persistent and rapid in onset, it results in irreversible injury and death of the affected cells. Cell death is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (lack of blood flow), infections, toxins, and immune reactions. Cell death also is a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. The relationships among normal, adapted, and revers- ibly and irreversibly injured cells are well illustrated by the responses of the heart to different types of stress (Fig. 1–2). Myocardium subjected to persistent increased load, as in hypertension or with a narrowed (stenotic) valve, adapts by undergoing hypertrophy—an increase in the size of the individual cells and ultimately the entire heart—to gener- ate the required higher contractile force. If the increased demandis not relieved, or if the myocardium is subjected to reduced blood flow (ischemia) from an occluded coro- nary artery, the muscle cells may undergo injury. Myocar- dium may be reversibly injured if the stress is mild or the arterial occlusion is incomplete or sufficiently brief, or it may undergo irreversible injury and cell death (infarction) after complete or prolonged occlusion. Also of note, stresses and injury affect not only the morphology but also the functional status of cells and tissues. Thus, reversibly injured myocytes are not dead and may resemble normal myocytes morphologically; however, they are transiently noncontractile, so even mild injury can have a significant Hipertensão, válvula estenótica Infarto agudo do miocárdio, PATOLOGIA – Adaptação celular Fisiológica Patológica -‐ FISIOLÓGICA HORMONAL: Hiperplasia do epitélio glandular da mama durante a puberdade e gravidez. -‐ FISIOLÓGICA COMPENSATÓRIA: Hepatócitos após hepatectomia Hiperplasia: Hepatectomia Hiperplasia fisiológica compensatória (hepatócitos) Cirrose hepática Hiperplasia patológica (fibroblastos) PATOLOGIA – Adaptação celular 18/03/20 2 Fisiológica Patológica Útero diminui de tamanho logo após o parto. Ateroscletorse leva a diminuição do suprimento sanguíneo. Atrofia: C H A P T E R 1 Cell Injury, Cell Death, and Adaptations4 after a normal menstrual period there is a burst of uterine epithelial proliferation that is normally tightly regulated by stimulation through pituitary hormones and ovarian estrogen and by inhibition through proges- terone. However, a disturbed balance between estrogen and progesterone causes endometrial hyperplasia, which is a common cause of abnormal menstrual bleeding. Hyperplasia also is an important response of connective tissue cells in wound healing, in which pro- liferating fibroblasts and blood vessels aid in repair (Chapter 2). In this process, growth factors are produced by white blood cells (leukocytes) responding to the injury and by cells in the extracellular matrix. Stimula- tion by growth factors also is involved in the hyperplasia that is associated with certain viral infections; for example, papillomaviruses cause skin warts and mucosal lesions composed of masses of hyperplastic epithelium. Here the growth factors may be encoded by viral genes or by the genes of the infected host cells. An important point is that in all of these situations, the hyperplastic process remains controlled; if the signals that initi- ate it abate, the hyperplasia disappears. It is this responsiveness to normal regulatory control mechanisms that distin- guishes pathologic hyperplasias from cancer, in which the growth control mechanisms become dysregulated or inef- fective (Chapter 5). Nevertheless, in many cases, pathologic hyperplasia constitutes a fertile soil in which cancers may eventually arise. For example, patients with hyperplasia of the endometrium are at increased risk of developing endo- metrial cancer (Chapter 18). Atrophy Shrinkage in the size of the cell by the loss of cell substance is known as atrophy. When a sufficient number of cells are involved, the entire tissue or organ diminishes in size, becoming atrophic (Fig. 1–4). Although atrophic cells may have diminished function, they are not dead. Causes of atrophy include a decreased workload (e.g., immobilization of a limb to permit healing of a fracture), can no longer compensate for the increased burden. When this happens in the heart, several “degenerative” changes occur in the myocardial fibers, of which the most important are fragmentation and loss of myofibrillar contractile ele- ments. The variables that limit continued hypertrophy and cause the regressive changes are incompletely understood. There may be finite limits of the vasculature to adequately supply the enlarged fibers, of the mitochondria to supply adenosine triphosphate (ATP), or of the biosynthetic machinery to provide the contractile proteins or other cyto- skeletal elements. The net result of these changes is ven- tricular dilation and ultimately cardiac failure, a sequence of events that illustrates how an adaptation to stress can progress to functionally significant cell injury if the stress is not relieved. Hyperplasia As discussed earlier, hyperplasia takes place if the tissue contains cell populations capable of replication; it may occur concurrently with hypertrophy and often in response to the same stimuli. Hyperplasia can be physiologic or pathologic. In both situa- tions, cellular proliferation is stimulated by growth factors that are produced by a variety of cell types. • The two types of physiologic hyperplasia are (1) hormonal hyperplasia, exemplified by the proliferation of the glan- dular epithelium of the female breast at puberty and during pregnancy, and (2) compensatory hyperplasia, in which residual tissue grows after removal or loss of part of an organ. For example, when part of a liver is resected, mitotic activity in the remaining cells begins as early as 12 hours later, eventually restoring the liver to its normal weight. The stimuli for hyperplasia in this setting are polypeptide growth factors produced by uninjured hepatocytes as well as nonparenchymal cells in the liver (Chapter 2). After restoration of the liver mass, cell pro- liferation is “turned off” by various growth inhibitors. • Most forms of pathologic hyperplasia are caused by exces- sive hormonal or growth factor stimulation. For example, Figure 1–4 Atrophy as seen in the brain. A, Normal brain of a young adult. B, Atrophy of the brain in an 82-year-old man with atherosclerotic disease. Atrophy of the brain is due to aging and reduced blood supply. Note that loss of brain substance narrows the gyri and widens the sulci. The meninges have been stripped from the bottom half of each specimen to reveal the surface of the brain. BA Adulto jovem Idoso (82 anos) 3Cellular Adaptations to Stress cells have a limited capacity to divide. Hypertrophy and hyperplasia also can occur together, and obviously both result in an enlarged (hypertrophic) organ. Hypertrophy can be physiologic or pathologic and is caused either by increased functional demand or by growth factor or hormonal stimulation. • The massive physiologic enlargement of the uterus during pregnancy occurs as a consequence of estrogen- stimulated smooth muscle hypertrophy and smooth muscle hyperplasia (Fig. 1–3). In contrast, in response to increased demand the striated muscle cells in both the skeletal muscle and the heart can undergo only hyper- trophy because adult muscle cells have a limited capac- ity to divide. Therefore, the chiseled physique of the avid weightlifter stems solely from the hypertrophy of individual skeletal muscles. • An example of pathologic cellular hypertrophy is the cardiac enlargement that occurs with hypertension or aortic valve disease (Fig. 1–2). The mechanisms driving cardiac hypertrophy involve at least two types of signals: mechanical triggers, such as stretch, and trophic triggers, which typically are soluble mediators that stimulate cell growth, such as growth factors and adrenergic hormones. These stimuli turn on signal transduction pathways that lead to the induction of a number of genes, which in turn stimulate synthesis of many cellular proteins, including growth factors and struc- tural proteins. The result is the synthesis of more proteins and myofilaments per cell, which increases the force gener- ated with each contraction, enabling the cell to meet increased work demands. There may also be a switch of contractile proteins from adult to fetal or neonatal forms. For example, during muscle hypertrophy, the α-myosin heavy chain is replaced by the β form of the myosin heavy chain, which produces slower, more energetically econom- ical contraction. Whatever the exact mechanisms of hypertrophy,a limit is reached beyond which the enlargement of muscle mass clinical impact. Whether a specific form of stress induces adaptation or causes reversible or irreversible injury depends not only on the nature and severity of the stress but also on several other variables, including basal cellular metabolism and blood and nutrient supply. In this chapter we discuss first how cells adapt to stresses and then the causes, mechanisms, and consequences of the various forms of acute cell damage, including reversible cell injury, subcellular alterations, and cell death. We con- clude with three other processes that affect cells and tissues: intracellular accumulations, pathologic calcification, and cell aging. CELLULAR ADAPTATIONS TO STRESS Adaptations are reversible changes in the number, size, phenotype, metabolic activity, or functions of cells in response to changes in their environment. Physiologic adap- tations usually represent responses of cells to normal stimu- lation by hormones or endogenous chemical mediators (e.g., the hormone-induced enlargement of the breast and uterus during pregnancy). Pathologic adaptations are responses to stress that allow cells to modulate their struc- ture and function and thus escape injury. Such adaptations can take several distinct forms. Hypertrophy Hypertrophy is an increase in the size of cells resulting in increase in the size of the organ. In contrast, hyperplasia (dis- cussed next) is characterized by an increase in cell number because of proliferation of differentiated cells and replace- ment by tissue stem cells. Stated another way, in pure hypertrophy there are no new cells, just bigger cells containing increased amounts of structural proteins and organelles. Hyperplasia is an adaptive response in cells capable of replication, whereas hypertrophy occurs when Figure 1–3 Physiologic hypertrophy of the uterus during pregnancy. A, Gross appearance of a normal uterus (right) and a gravid uterus (left) that was removed for postpartum bleeding. B, Small spindle-shaped uterine smooth muscle cells from a normal uterus. C, Large, plump hypertrophied smooth muscle cells from a gravid uterus; compare with B. (B and C, Same magnification.) A B C 3Cellular Adaptations to Stress cells have a limited capacity to divide. Hypertrophy and hyperplasia also can occur together, and obviously both result in an enlarged (hypertrophic) organ. Hypertrophy can be physiologic or pathologic and is caused either by increased functional demand or by growth factor or hormonal stimulation. • The massive physiologic enlargement of the uterus during pregnancy occurs as a consequence of estrogen- stimulated smooth muscle hypertrophy and smooth muscle hyperplasia (Fig. 1–3). In contrast, in response to increased demand the striated muscle cells in both the skeletal muscle and the heart can undergo only hyper- trophy because adult muscle cells have a limited capac- ity to divide. Therefore, the chiseled physique of the avid weightlifter stems solely from the hypertrophy of individual skeletal muscles. • An example of pathologic cellular hypertrophy is the cardiac enlargement that occurs with hypertension or aortic valve disease (Fig. 1–2). The mechanisms driving cardiac hypertrophy involve at least two types of signals: mechanical triggers, such as stretch, and trophic triggers, which typically are soluble mediators that stimulate cell growth, such as growth factors and adrenergic hormones. These stimuli turn on signal transduction pathways that lead to the induction of a number of genes, which in turn stimulate synthesis of many cellular proteins, including growth factors and struc- tural proteins. The result is the synthesis of more proteins and myofilaments per cell, which increases the force gener- ated with each contraction, enabling the cell to meet increased work demands. There may also be a switch of contractile proteins from adult to fetal or neonatal forms. For example, during muscle hypertrophy, the α-myosin heavy chain is replaced by the β form of the myosin heavy chain, which produces slower, more energetically econom- ical contraction. Whatever the exact mechanisms of hypertrophy, a limit is reached beyond which the enlargement of muscle mass clinical impact. Whether a specific form of stress induces adaptation or causes reversible or irreversible injury depends not only on the nature and severity of the stress but also on several other variables, including basal cellular metabolism and blood and nutrient supply. In this chapter we discuss first how cells adapt to stresses and then the causes, mechanisms, and consequences of the various forms of acute cell damage, including reversible cell injury, subcellular alterations, and cell death. We con- clude with three other processes that affect cells and tissues: intracellular accumulations, pathologic calcification, and cell aging. CELLULAR ADAPTATIONS TO STRESS Adaptations are reversible changes in the number, size, phenotype, metabolic activity, or functions of cells in response to changes in their environment. Physiologic adap- tations usually represent responses of cells to normal stimu- lation by hormones or endogenous chemical mediators (e.g., the hormone-induced enlargement of the breast and uterus during pregnancy). Pathologic adaptations are responses to stress that allow cells to modulate their struc- ture and function and thus escape injury. Such adaptations can take several distinct forms. Hypertrophy Hypertrophy is an increase in the size of cells resulting in increase in the size of the organ. In contrast, hyperplasia (dis- cussed next) is characterized by an increase in cell number because of proliferation of differentiated cells and replace- ment by tissue stem cells. Stated another way, in pure hypertrophy there are no new cells, just bigger cells containing increased amounts of structural proteins and organelles. Hyperplasia is an adaptive response in cells capable of replication, whereas hypertrophy occurs when Figure 1–3 Physiologic hypertrophy of the uterus during pregnancy. A, Gross appearance of a normal uterus (right) and a gravid uterus (left) that was removed for postpartum bleeding. B, Small spindle-shaped uterine smooth muscle cells from a normal uterus. C, Large, plump hypertrophied smooth muscle cells from a gravid uterus; compare with B. (B and C, Same magnification.) A B C 3Cellular Adaptations to Stress cells have a limited capacity to divide. Hypertrophy and hyperplasia also can occur together, and obviously both result in an enlarged (hypertrophic) organ. Hypertrophy can be physiologic or pathologic and is caused either by increased functional demand or by growth factor or hormonal stimulation. • The massive physiologic enlargement of the uterus during pregnancy occurs as a consequence of estrogen- stimulated smooth muscle hypertrophy and smooth muscle hyperplasia (Fig. 1–3). In contrast, in response to increased demand the striated muscle cells in both the skeletal muscle and the heart can undergo only hyper- trophy because adult muscle cells have a limited capac- ity to divide. Therefore, the chiseled physique of the avid weightlifter stems solely from the hypertrophy of individual skeletal muscles. • An example of pathologic cellular hypertrophy is the cardiac enlargement that occurs with hypertension or aortic valve disease (Fig. 1–2). The mechanisms driving cardiac hypertrophy involve at least two types of signals: mechanical triggers, such as stretch, and trophic triggers, which typically are soluble mediators that stimulate cell growth, such as growth factors and adrenergic hormones. These stimuli turn on signal transduction pathways that lead to the induction of a number of genes, which in turn stimulate synthesis of many cellular proteins, including growth factors and struc- tural proteins. The result is the synthesis of more proteins and myofilaments percell, which increases the force gener- ated with each contraction, enabling the cell to meet increased work demands. There may also be a switch of contractile proteins from adult to fetal or neonatal forms. For example, during muscle hypertrophy, the α-myosin heavy chain is replaced by the β form of the myosin heavy chain, which produces slower, more energetically econom- ical contraction. Whatever the exact mechanisms of hypertrophy, a limit is reached beyond which the enlargement of muscle mass clinical impact. Whether a specific form of stress induces adaptation or causes reversible or irreversible injury depends not only on the nature and severity of the stress but also on several other variables, including basal cellular metabolism and blood and nutrient supply. In this chapter we discuss first how cells adapt to stresses and then the causes, mechanisms, and consequences of the various forms of acute cell damage, including reversible cell injury, subcellular alterations, and cell death. We con- clude with three other processes that affect cells and tissues: intracellular accumulations, pathologic calcification, and cell aging. CELLULAR ADAPTATIONS TO STRESS Adaptations are reversible changes in the number, size, phenotype, metabolic activity, or functions of cells in response to changes in their environment. Physiologic adap- tations usually represent responses of cells to normal stimu- lation by hormones or endogenous chemical mediators (e.g., the hormone-induced enlargement of the breast and uterus during pregnancy). Pathologic adaptations are responses to stress that allow cells to modulate their struc- ture and function and thus escape injury. Such adaptations can take several distinct forms. Hypertrophy Hypertrophy is an increase in the size of cells resulting in increase in the size of the organ. In contrast, hyperplasia (dis- cussed next) is characterized by an increase in cell number because of proliferation of differentiated cells and replace- ment by tissue stem cells. Stated another way, in pure hypertrophy there are no new cells, just bigger cells containing increased amounts of structural proteins and organelles. Hyperplasia is an adaptive response in cells capable of replication, whereas hypertrophy occurs when Figure 1–3 Physiologic hypertrophy of the uterus during pregnancy. A, Gross appearance of a normal uterus (right) and a gravid uterus (left) that was removed for postpartum bleeding. B, Small spindle-shaped uterine smooth muscle cells from a normal uterus. C, Large, plump hypertrophied smooth muscle cells from a gravid uterus; compare with B. (B and C, Same magnification.) A B C PATOLOGIA – Adaptação celular Metaplasia: 5Cellular Adaptations to Stress epithelium. Metaplasia need not always occur in the direc- tion of columnar to squamous epithelium; in chronic gastric reflux, the normal stratified squamous epithelium of the lower esophagus may undergo metaplastic transformation to gastric or intestinal-type columnar epithelium. Metapla- sia may also occur in mesenchymal cells but in these situ- ations it is generally a reaction to some pathologic alteration and not an adaptive response to stress. For example, bone is occasionally formed in soft tissues, particularly in foci of injury. loss of innervation, diminished blood supply, inadequate nutrition, loss of endocrine stimulation, and aging (senile atrophy). Although some of these stimuli are physiologic (e.g., the loss of hormone stimulation in menopause) and others pathologic (e.g., denervation), the fundamental cel- lular changes are identical. They represent a retreat by the cell to a smaller size at which survival is still possible; a new equilibrium is achieved between cell size and dimin- ished blood supply, nutrition, or trophic stimulation. The mechanisms of atrophy consist of a combination of decreased protein synthesis and increased protein degradation in cells. • Protein synthesis decreases because of reduced meta- bolic activity. • The degradation of cellular proteins occurs mainly by the ubiquitin-proteasome pathway. Nutrient deficiency and disuse may activate ubiquitin ligases, which attach mul- tiple copies of the small peptide ubiquitin to cellular proteins and target them for degradation in protea- somes. This pathway is also thought to be responsible for the accelerated proteolysis seen in a variety of cata- bolic conditions, including the cachexia associated with cancer. • In many situations, atrophy is also accompanied by increased autophagy, with resulting increases in the number of autophagic vacuoles. Autophagy (“self-eating”) is the process in which the starved cell eats its own components in an attempt to survive. We describe this process later in the chapter. Metaplasia Metaplasia is a reversible change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type. In this type of cellular adaptation, a cell type sensitive to a particular stress is replaced by another cell type better able to withstand the adverse environment. Metaplasia is thought to arise by reprogramming of stem cells to differ- entiate along a new pathway rather than a phenotypic change (transdifferentiation) of already differentiated cells. Epithelial metaplasia is exemplified by the squamous change that occurs in the respiratory epithelium of habitual cigarette smokers (Fig. 1–5). The normal ciliated columnar epithelial cells of the trachea and bronchi are focally or widely replaced by stratified squamous epithelial cells. The rugged stratified squamous epithelium may be able to survive the noxious chemicals in cigarette smoke that the more fragile specialized epithelium would not tolerate. Although the metaplastic squamous epithelium has survival advantages, important protective mechanisms are lost, such as mucus secretion and ciliary clearance of particulate matter. Epithelial metaplasia is therefore a double-edged sword. Moreover, the influences that induce metaplastic change, if per- sistent, may predispose to malignant transformation of the epi- thelium. In fact, squamous metaplasia of the respiratory epithelium often coexists with lung cancers composed of malignant squamous cells. It is thought that cigarette smoking initially causes squamous metaplasia, and cancers arise later in some of these altered foci. Since vitamin A is essential for normal epithelial differentiation, its deficiency may also induce squamous metaplasia in the respiratory Figure 1–5 Metaplasia of normal columnar (left) to squamous epithe- lium (right) in a bronchus, shown schematically (A) and histologically (B). B Normal columnar epithelium Basement membrane Squamous metaplasia A SUMMARY Cellular Adaptations to Stress • Hypertrophy: increased cell and organ size, often in response to increased workload; induced by growth factors produced in response to mechanical stress or other stimuli; occurs in tissues incapable of cell division • Hyperplasia: increased cell numbers in response to hor- mones and other growth factors; occurs in tissues whose cells are able to divide or contain abundant tissue stem cells • Atrophy: decreased cell and organ size, as a result of decreased nutrient supply or disuse; associated with decreased synthesis of cellular building blocks and increased breakdown of cellular organelles • Metaplasia: change in phenotype of differentiated cells, often in response to chronic irritation, that makes cells better able to withstand the stress; usually induced by altered differentiation pathway of tissue stem cells; may result in reduced functions or increased propensity for malignant transformation Metaplasia do epitélio colunar (à esquerda) para epitélio escamoso (à direita) em um brônquio. PATOLOGIA – Adaptação celular Lesão celular: § Causas § Características bioquimicas e morfológicas § Mecanismos PATOLOGIA – Lesão emorte celular Estágios na resposta celular ao estresse e estímulos nocivos: Lesão celular Hipóxia Agentes químicos Agentes infecciosos Resposta imunológica Fatores genéticos Desbalanço nutricional Agentes físicos Envelheci-‐ mento PATOLOGIA – Lesão e morte celular Causas das lesões celulares PATOLOGIA – Lesão e morte celular Características bioquímicas e morfológicas na lesão celular § A lesão celular é resultante de diferentesmecanismos bioquímicos que agem em vários componentes celulares essenciais. § Componentes celulares mais frequentemente lesados por estímulos nocivos: ü Mitocôndrias, ü Membranas celulares, ü Maquinaria de síntese e empacotamento de proteínas, ü DNA. § Qualquer estímulo nocivo pode, simultaneamente, iniciar múltiplos mecanismos que lesam as células. PATOLOGIA – Lesão e morte celular Mecanismos da lesão celular: 18/03/20 3 Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular ERO: Espécies reativas de oxigênio. Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Depleção de ATP: § Principais causas de depleção de ATP: • Redução de oxigênio e nutrientes, • Danos mitocondriais, • Ação de algumas toxinas (ex., cianeto). § Célula se torna incapaz de realizar funções que dependem de ATP. § A privação de O2 ou glicose, pode levar a injúria reversível, e se o quadro se manter, ocorre necrose. § Produção de ATP (mitocôndria): -‐ fosforilação oxidativa -‐ via glicolítica Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Depleção de ATP: Consequências morfológicas e funcionais da diminuição de ATP intracelular durante a lesão. Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Dano Mitocondrial: § Danificadas por: • éCa2+ citosólico, • ERO, • ê Oxigênio, • Mutações nos genes mitocondriais. § Quadro pode evoluir: • Depleção de ATP, levando a necrose. • Vazamento de proteínas mitocondriais levando a apoptose. Extravasamento de proteínas pró-‐apoptóticas Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Influxo de Cálcio: § Cálcio: normalmente mais concentrado fora da célula, ou dentro de organelas como o retículo endoplasmático. § Lesões: ativa enzimas diversas: • Danificam a célula e seus componentes. • Ativam a via apoptótica. Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Acúmulo de ERO (stress oxidativo): § Modificação covalente de proteínas, lipídeos e ácidos nucléicos. § Lesão celular e morte por necrose ou apoptose. ERO (radical livre derivado do oxigênio/ Espécies reativas de oxigênio): § Produzidos: normalmente nas células durante a respiração e geração de energia mitocondrial. § Degradados e removidos: pelas celulas de defesa. 18/03/20 4 Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Aumento da permeabilidade das membranas celulares: § Afeta membranas: plasmáticas, lisossomais, mitocondriais. § Geralmente leva a necrose mas pode ocorrer apoptose. Mecanismos de lesão celular: PATOLOGIA – Lesão e morte celular Acúmulo de danos ao DNA e proteínas anormalmente dobradas: § Ativação da apoptose. PATOLOGIA – Lesão e morte celular Morte celular Necrose: C H A P T E R 1 Cell Injury, Cell Death, and Adaptations6 cell, resulting in necrosis. Cellular contents also leak through the damaged plasma membrane into the extra- cellular space, where they elicit a host reaction (inflam- mation). Necrosis is the major pathway of cell death in many commonly encountered injuries, such as those resulting from ischemia, exposure to toxins, various infections, and trauma. When a cell is deprived of growth factors, or the cell’s DNA or proteins are damaged beyond repair, typically the cell kills itself by another type of death, called apoptosis, which is charac- terized by nuclear dissolution without complete loss of membrane integrity. Whereas necrosis is always a patho- logic process, apoptosis serves many normal functions and is not necessarily associated with pathologic cell injury. Further- more, in keeping with its role in certain physiologic processes, apoptosis does not elicit an inflammatory response. The mor- phologic features, mechanisms, and significance of these two death pathways are discussed in more detail later in the chapter. CAUSES OF CELL INJURY The causes of cell injury range from the gross physical trauma of a motor vehicle accident to the single gene defect that results in a nonfunctional enzyme underlying a Figure 1–6 Cellular features of necrosis (left) and apoptosis (right). Apoptotic body Condensation of chromatin Membrane blebs Phagocyte Phagocytosisof apoptotic cells and fragments Reversible injury Progressive injury Inflammation Recovery NORMAL CELL NORMAL CELL NECROSIS APOPTOSIS Swelling of endoplasmic reticulum and mitochondria Membrane blebs Myelin figures Amorphous densities in mitochondria Breakdown of plasma membrane, organelles, and nucleus; leakage of contents Cellular fragmentation Myelin figure OVERVIEW OF CELL INJURY AND CELL DEATH As stated at the beginning of the chapter, cell injury results when cells are stressed so severely that they are no longer able to adapt or when cells are exposed to inherently dam- aging agents or suffer from intrinsic abnormalities (e.g., in DNA or proteins). Different injurious stimuli affect many metabolic pathways and cellular organelles. Injury may progress through a reversible stage and culminate in cell death (Fig. 1–1). • Reversible cell injury. In early stages or mild forms of injury the functional and morphologic changes are reversible if the damaging stimulus is removed. At this stage, although there may be significant structural and functional abnormalities, the injury has typically not progressed to severe membrane damage and nuclear dissolution. • Cell death. With continuing damage, the injury becomes irreversible, at which time the cell cannot recover and it dies. There are two types of cell death—necrosis and apoptosis—which differ in their mechanisms, morphology, and roles in disease and physiology (Fig. 1–6 and Table 1–1). When damage to membranes is severe, enzymes leak out of lysosomes, enter the cytoplasm, and digest the Tumefação generalizada da célula e suas organelas Bolhas na membrana plasmática Densidades amorfas na mitocôndria Rompimento das membranas do núcleo, das organelas e plasmática e extravasamento de conteúdo Alterações morfológicas da lesão celular que culminam em necrose: Inflamação Recuperação Injúria reverssível Figuras de mielina Injúria progressiva PATOLOGIA – Lesão e morte celular C H A P T E R 1 Cell Injury, Cell Death, and Adaptations6 cell, resulting in necrosis. Cellular contents also leak through the damaged plasma membrane into the extra- cellular space, where they elicit a host reaction (inflam- mation). Necrosis is the major pathway of cell death in many commonly encountered injuries, such as those resulting from ischemia, exposure to toxins, various infections, and trauma. When a cell is deprived of growth factors, or the cell’s DNA or proteins are damaged beyond repair, typically the cell kills itself by another type of death, called apoptosis, which is charac- terized by nuclear dissolution without complete loss of membrane integrity. Whereas necrosis is always a patho- logic process, apoptosis serves many normal functions and is not necessarily associated with pathologic cell injury. Further- more, in keeping with its role in certain physiologic processes, apoptosis does not elicit an inflammatory response. The mor- phologic features, mechanisms, and significance of thesetwo death pathways are discussed in more detail later in the chapter. CAUSES OF CELL INJURY The causes of cell injury range from the gross physical trauma of a motor vehicle accident to the single gene defect that results in a nonfunctional enzyme underlying a Figure 1–6 Cellular features of necrosis (left) and apoptosis (right). Apoptotic body Condensation of chromatin Membrane blebs Phagocyte Phagocytosisof apoptotic cells and fragments Reversible injury Progressive injury Inflammation Recovery NORMAL CELL NORMAL CELL NECROSIS APOPTOSIS Swelling of endoplasmic reticulum and mitochondria Membrane blebs Myelin figures Amorphous densities in mitochondria Breakdown of plasma membrane, organelles, and nucleus; leakage of contents Cellular fragmentation Myelin figure OVERVIEW OF CELL INJURY AND CELL DEATH As stated at the beginning of the chapter, cell injury results when cells are stressed so severely that they are no longer able to adapt or when cells are exposed to inherently dam- aging agents or suffer from intrinsic abnormalities (e.g., in DNA or proteins). Different injurious stimuli affect many metabolic pathways and cellular organelles. Injury may progress through a reversible stage and culminate in cell death (Fig. 1–1). • Reversible cell injury. In early stages or mild forms of injury the functional and morphologic changes are reversible if the damaging stimulus is removed. At this stage, although there may be significant structural and functional abnormalities, the injury has typically not progressed to severe membrane damage and nuclear dissolution. • Cell death. With continuing damage, the injury becomes irreversible, at which time the cell cannot recover and it dies. There are two types of cell death—necrosis and apoptosis—which differ in their mechanisms, morphology, and roles in disease and physiology (Fig. 1–6 and Table 1–1). When damage to membranes is severe, enzymes leak out of lysosomes, enter the cytoplasm, and digest the Morte celular Apoptose: Alterações morfológicas da lesão celular que culminam em apoptose. Bolhas na membrana plasmática Condensação da cromatina Corpos apoptóticos Fagócito Fagocitose da célula e corpos apoptóticos Fragmentação celular Lesão reversível Eventos limiares Lesão irreversível (Necrose) •Inchaço; •Alterações na membrana plasmática (bolhas e distorções); •Alterações mitocondriais (edema, densidades amorfas); •Acúmulo de vacúolos lipídicos; •Hipertrofia do RE (separação e desagregação de polissomos) •Disfunção mitocondrial; •Rompimento da membrana plasmática. •Extravasamento de conteúdo celular; •Inflamação; •Eosinofilia citoplasmática; •Citoplasma vacuolado; •Cariólise; •Picnose; •Cariorréxis PATOLOGIA – Lesão e morte celular Características morfológicas das lesões celulares PATOLOGIA – Lesão e morte celular Necrose – alterações nucleares Características morfológicas das lesões celulares 18/03/20 5 De Coagulação De Liquefação Caseosa Gordurosa Fibrinoide PATOLOGIA – Lesão e morte celular Necrose Necrose: Características morfológicas das lesões celulares Lítica: hepatite viral Gomosa: sífilis tardia Gangrenosa: membros Esteatonecrose: adipócitos C H A P T E R 1 Cell Injury, Cell Death, and Adaptations10 B I N A Figure 1–9 Coagulative necrosis. A, A wedge-shaped kidney infarct (yellow) with preservation of the outlines. B, Microscopic view of the edge of the infarct, with normal kidney (N) and necrotic cells in the infarct (I). The necrotic cells show preserved outlines with loss of nuclei, and an inflamma- tory infiltrate is present (difficult to discern at this magnification). Figure 1–10 Liquefactive necrosis. An infarct in the brain showing dissolution of the tissue. MORPHOLOGY • Coagulative necrosis is a form of necrosis in which the underlying tissue architecture is preserved for at least several days (Fig. 1–9). The affected tissues take on a firm texture. Presumably the injury denatures not only struc- tural proteins but also enzymes, thereby blocking the pro- teolysis of the dead cells; as a result, eosinophilic, anucleate cells may persist for days or weeks. Leukocytes are recruited to the site of necrosis, and the dead cells are digested by the action of lysosomal enzymes of the leu- kocytes. The cellular debris is then removed by phagocy- tosis. Coagulative necrosis is characteristic of infarcts (areas of ischemic necrosis) in all of the solid organs except the brain. • Liquefactive necrosis is seen in focal bacterial or, occasionally, fungal infections, because microbes stimulate the accumulation of inflammatory cells and the enzymes of leukocytes digest (“liquefy”) the tissue. For obscure reasons, hypoxic death of cells within the central nervous system often evokes liquefactive necrosis (Fig. 1–10). Whatever the pathogenesis, the dead cells are completely digested, transforming the tissue into a liquid viscous mass. Eventually, the digested tissue is removed by phagocytes. If the process was initiated by acute inflammation, as in a bacterial infection, the material is frequently creamy yellow and is called pus (Chapter 2). • Although gangrenous necrosis is not a distinctive pattern of cell death, the term is still commonly used in clinical practice. It usually refers to the condition of a limb, generally the lower leg, that has lost its blood supply and has undergone coagulative necrosis involving multiple tissue layers. When bacterial infection is superimposed, coagulative necrosis is modified by the liquefactive action of the bacteria and the attracted leukocytes (resulting in so-called wet gangrene). • Caseous necrosis is encountered most often in foci of tuberculous infection. Caseous means “cheese-like,” referring to the friable yellow-white appearance of the area of necrosis (Fig. 1–11). On microscopic examination, the necrotic focus appears as a collection of fragmented or lysed cells with an amorphous granular pink appearance in the usual H&E-stained tissue. Unlike with coagulative necrosis, the tissue architecture is completely obliterated and cellular outlines cannot be discerned. The area of caseous necrosis is often enclosed within a distinctive inflammatory border; this appearance is characteristic of a focus of inflammation known as a granuloma (Chapter 2). • Fat necrosis refers to focal areas of fat destruction, typi- cally resulting from release of activated pancreatic lipases into the substance of the pancreas and the peritoneal cavity. This occurs in the calamitous abdominal emergency known as acute pancreatitis (Chapter 16). In this disorder, pancreatic enzymes that have leaked out of acinar cells § Arquitetura do órgão é geralmente mantida por algum tempo. § Infiltrado inflamatório. § Uma área localizada de necrose de coagulação é chamada de infarto, exceto no cérebro. PATOLOGIA – Lesão e morte celular Necrose da coagulação: Lesão Desnatura enzimas Bloqueando a proteólise A. Infarto renal. B, Aspecto microscópico da borda do infarto, com rim normal (N) e células necróticas no infarto (I), mostrando contornos preservados, com ausência de núcleos e um infiltrado inflamatório C H A P T E R 1 Cell Injury, Cell Death, and Adaptations10 B I N A Figure 1–9 Coagulative necrosis. A, A wedge-shaped kidney infarct (yellow) with preservation of the outlines. B, Microscopic view of the edge of the infarct, with normal kidney (N) and necrotic cells in the infarct (I). The necrotic cells show preserved outlines with loss of nuclei, and an inflamma- tory infiltrate is present (difficult to discern at this magnification). Figure 1–10 Liquefactive necrosis. An infarct in the brain showing dissolution of the tissue. MORPHOLOGY • Coagulative necrosis is a form of necrosis in which the underlying tissue architectureis preserved for at least several days (Fig. 1–9). The affected tissues take on a firm texture. Presumably the injury denatures not only struc- tural proteins but also enzymes, thereby blocking the pro- teolysis of the dead cells; as a result, eosinophilic, anucleate cells may persist for days or weeks. Leukocytes are recruited to the site of necrosis, and the dead cells are digested by the action of lysosomal enzymes of the leu- kocytes. The cellular debris is then removed by phagocy- tosis. Coagulative necrosis is characteristic of infarcts (areas of ischemic necrosis) in all of the solid organs except the brain. • Liquefactive necrosis is seen in focal bacterial or, occasionally, fungal infections, because microbes stimulate the accumulation of inflammatory cells and the enzymes of leukocytes digest (“liquefy”) the tissue. For obscure reasons, hypoxic death of cells within the central nervous system often evokes liquefactive necrosis (Fig. 1–10). Whatever the pathogenesis, the dead cells are completely digested, transforming the tissue into a liquid viscous mass. Eventually, the digested tissue is removed by phagocytes. If the process was initiated by acute inflammation, as in a bacterial infection, the material is frequently creamy yellow and is called pus (Chapter 2). • Although gangrenous necrosis is not a distinctive pattern of cell death, the term is still commonly used in clinical practice. It usually refers to the condition of a limb, generally the lower leg, that has lost its blood supply and has undergone coagulative necrosis involving multiple tissue layers. When bacterial infection is superimposed, coagulative necrosis is modified by the liquefactive action of the bacteria and the attracted leukocytes (resulting in so-called wet gangrene). • Caseous necrosis is encountered most often in foci of tuberculous infection. Caseous means “cheese-like,” referring to the friable yellow-white appearance of the area of necrosis (Fig. 1–11). On microscopic examination, the necrotic focus appears as a collection of fragmented or lysed cells with an amorphous granular pink appearance in the usual H&E-stained tissue. Unlike with coagulative necrosis, the tissue architecture is completely obliterated and cellular outlines cannot be discerned. The area of caseous necrosis is often enclosed within a distinctive inflammatory border; this appearance is characteristic of a focus of inflammation known as a granuloma (Chapter 2). • Fat necrosis refers to focal areas of fat destruction, typi- cally resulting from release of activated pancreatic lipases into the substance of the pancreas and the peritoneal cavity. This occurs in the calamitous abdominal emergency known as acute pancreatitis (Chapter 16). In this disorder, pancreatic enzymes that have leaked out of acinar cells § Digestão das células mortas, resultando na transformação do tecido em umamassa viscosa líquida. § Geralmente em infecção bacteriana ou fúngica, que estimulam o acúmulo de leucócitos e a liberação de enzimas dessas células. § Ex: Pus. PATOLOGIA – Lesão e morte celular Necrose de liquefação: Infarto no cérebro, mostrando a dissolução do tecido. 11Mechanisms of Cell Injury Figure 1–11 Caseous necrosis. Tuberculosis of the lung, with a large area of caseous necrosis containing yellow-white (cheesy) debris. Figure 1–12 Fat necrosis in acute pancreatitis. The areas of white chalky deposits represent foci of fat necrosis with calcium soap formation (saponification) at sites of lipid breakdown in the mesentery. Figure 1–13 Fibrinoid necrosis in an artery in a patient with polyarteritis nodosa. The wall of the artery shows a circumferential bright pink area of necrosis with protein deposition and inflammation. Leakage of intracellular proteins through the damaged cell membrane and ultimately into the circulation provides a means of detecting tissue-specific necrosis using blood or serum samples. Cardiac muscle, for example, contains a unique isoform of the enzyme creatine kinase and of the contractile protein troponin, whereas hepatic bile duct epithelium contains a temperature-resistant isoform of the enzyme alkaline phos- phatase, and hepatocytes contain transaminases. Irrevers- ible injury and cell death in these tissues result in increased serum levels of such proteins, and measurement of serum levels is used clinically to assess damage to these tissues. SUMMARY Morphologic Alterations in Injured Cells and Tissues • Reversible cell injury: cell swelling, fatty change, plasma membrane blebbing and loss of microvilli, mitochondrial swelling, dilation of the ER, eosinophilia (due to decreased cytoplasmic RNA) • Necrosis: increased eosinophilia; nuclear shrinkage, frag- mentation, and dissolution; breakdown of plasma mem- brane and organellar membranes; abundant myelin figures; leakage and enzymatic digestion of cellular contents • Patterns of tissue necrosis: Under different conditions, necrosis in tissues may assume specific patterns: coagula- tive, liquefactive, gangrenous, caseous, fat, and fibrinoid. and ducts liquefy the membranes of fat cells in the peri- toneum, and lipases split the triglyceride esters contained within fat cells. The released fatty acids combine with calcium to produce grossly visible chalky white areas (fat saponification), which enable the surgeon and the patholo- gist to identify the lesions (Fig. 1–12). On histologic exami- nation, the foci of necrosis contain shadowy outlines of necrotic fat cells with basophilic calcium deposits, sur- rounded by an inflammatory reaction. • Fibrinoid necrosis is a special form of necrosis, visible by light microscopy, usually in immune reactions in which complexes of antigens and antibodies are deposited in the walls of arteries. The deposited immune complexes, together with fibrin that has leaked out of vessels, produce a bright pink and amorphous appearance on H&E prepara- tions called fibrinoid (fibrin-like) by pathologists (Fig. 1–13). The immunologically mediated diseases (e.g., poly- arteritis nodosa) in which this type of necrosis is seen are described in Chapter 4. MECHANISMS OF CELL INJURY Now that we have discussed the causes of cell injury and the morphologic changes in necrosis, we next consider in more detail the molecular basis of cell injury, and then illustrate the important principles with a few selected examples of common types of injury. The biochemical mechanisms linking any given injury with the resulting cellular and tissue manifestations are complex, interconnected, and tightly interwoven with many intracellular metabolic pathways. Nevertheless, § “caseoso”: semelhante a queijo; § Encontrada comumente em focos de tuberculose; § Arquitetura tecidual alterada; § Células rompidas ou fragmentadas e restos granulares amorfos encerrados dentro de uma borda inflamatória nítida; § Típica de granulomas. PATOLOGIA – Lesão e morte celular Necrose caseosa: Necrose caseosa. Pulmão tuberculoso 11Mechanisms of Cell Injury Figure 1–11 Caseous necrosis. Tuberculosis of the lung, with a large area of caseous necrosis containing yellow-white (cheesy) debris. Figure 1–12 Fat necrosis in acute pancreatitis. The areas of white chalky deposits represent foci of fat necrosis with calcium soap formation (saponification) at sites of lipid breakdown in the mesentery. Figure 1–13 Fibrinoid necrosis in an artery in a patient with polyarteritis nodosa. The wall of the artery shows a circumferential bright pink area of necrosis with protein deposition and inflammation. Leakage of intracellular proteins through the damaged cell membrane and ultimately into the circulation provides a means of detecting tissue-specific necrosis using blood or serum samples. Cardiac muscle, for example, contains a unique isoform of the enzyme creatine kinase and of the contractileprotein troponin, whereas hepatic bile duct epithelium contains a temperature-resistant isoform of the enzyme alkaline phos- phatase, and hepatocytes contain transaminases. Irrevers- ible injury and cell death in these tissues result in increased serum levels of such proteins, and measurement of serum levels is used clinically to assess damage to these tissues. SUMMARY Morphologic Alterations in Injured Cells and Tissues • Reversible cell injury: cell swelling, fatty change, plasma membrane blebbing and loss of microvilli, mitochondrial swelling, dilation of the ER, eosinophilia (due to decreased cytoplasmic RNA) • Necrosis: increased eosinophilia; nuclear shrinkage, frag- mentation, and dissolution; breakdown of plasma mem- brane and organellar membranes; abundant myelin figures; leakage and enzymatic digestion of cellular contents • Patterns of tissue necrosis: Under different conditions, necrosis in tissues may assume specific patterns: coagula- tive, liquefactive, gangrenous, caseous, fat, and fibrinoid. and ducts liquefy the membranes of fat cells in the peri- toneum, and lipases split the triglyceride esters contained within fat cells. The released fatty acids combine with calcium to produce grossly visible chalky white areas (fat saponification), which enable the surgeon and the patholo- gist to identify the lesions (Fig. 1–12). On histologic exami- nation, the foci of necrosis contain shadowy outlines of necrotic fat cells with basophilic calcium deposits, sur- rounded by an inflammatory reaction. • Fibrinoid necrosis is a special form of necrosis, visible by light microscopy, usually in immune reactions in which complexes of antigens and antibodies are deposited in the walls of arteries. The deposited immune complexes, together with fibrin that has leaked out of vessels, produce a bright pink and amorphous appearance on H&E prepara- tions called fibrinoid (fibrin-like) by pathologists (Fig. 1–13). The immunologically mediated diseases (e.g., poly- arteritis nodosa) in which this type of necrosis is seen are described in Chapter 4. MECHANISMS OF CELL INJURY Now that we have discussed the causes of cell injury and the morphologic changes in necrosis, we next consider in more detail the molecular basis of cell injury, and then illustrate the important principles with a few selected examples of common types of injury. The biochemical mechanisms linking any given injury with the resulting cellular and tissue manifestations are complex, interconnected, and tightly interwoven with many intracellular metabolic pathways. Nevertheless, § Áreas de destruição de gordura que ocorre como resultado da liberação de lipases pancreáticas ativadas na cavidade abdominal, como na pancreatite aguda. § Os ácidos graxos liberados combinam-‐se com o cálcio, produzindo áreas brancas gredosas (argilosa) macroscopicamente visíveis (saponificação da gordura). PATOLOGIA – Lesão e morte celular Necrose gordurosa: Necrose gordurosa: As áreas de depósitos gredosos, brancas, representam focos de necrose gordurosa. 11Mechanisms of Cell Injury Figure 1–11 Caseous necrosis. Tuberculosis of the lung, with a large area of caseous necrosis containing yellow-white (cheesy) debris. Figure 1–12 Fat necrosis in acute pancreatitis. The areas of white chalky deposits represent foci of fat necrosis with calcium soap formation (saponification) at sites of lipid breakdown in the mesentery. Figure 1–13 Fibrinoid necrosis in an artery in a patient with polyarteritis nodosa. The wall of the artery shows a circumferential bright pink area of necrosis with protein deposition and inflammation. Leakage of intracellular proteins through the damaged cell membrane and ultimately into the circulation provides a means of detecting tissue-specific necrosis using blood or serum samples. Cardiac muscle, for example, contains a unique isoform of the enzyme creatine kinase and of the contractile protein troponin, whereas hepatic bile duct epithelium contains a temperature-resistant isoform of the enzyme alkaline phos- phatase, and hepatocytes contain transaminases. Irrevers- ible injury and cell death in these tissues result in increased serum levels of such proteins, and measurement of serum levels is used clinically to assess damage to these tissues. SUMMARY Morphologic Alterations in Injured Cells and Tissues • Reversible cell injury: cell swelling, fatty change, plasma membrane blebbing and loss of microvilli, mitochondrial swelling, dilation of the ER, eosinophilia (due to decreased cytoplasmic RNA) • Necrosis: increased eosinophilia; nuclear shrinkage, frag- mentation, and dissolution; breakdown of plasma mem- brane and organellar membranes; abundant myelin figures; leakage and enzymatic digestion of cellular contents • Patterns of tissue necrosis: Under different conditions, necrosis in tissues may assume specific patterns: coagula- tive, liquefactive, gangrenous, caseous, fat, and fibrinoid. and ducts liquefy the membranes of fat cells in the peri- toneum, and lipases split the triglyceride esters contained within fat cells. The released fatty acids combine with calcium to produce grossly visible chalky white areas (fat saponification), which enable the surgeon and the patholo- gist to identify the lesions (Fig. 1–12). On histologic exami- nation, the foci of necrosis contain shadowy outlines of necrotic fat cells with basophilic calcium deposits, sur- rounded by an inflammatory reaction. • Fibrinoid necrosis is a special form of necrosis, visible by light microscopy, usually in immune reactions in which complexes of antigens and antibodies are deposited in the walls of arteries. The deposited immune complexes, together with fibrin that has leaked out of vessels, produce a bright pink and amorphous appearance on H&E prepara- tions called fibrinoid (fibrin-like) by pathologists (Fig. 1–13). The immunologically mediated diseases (e.g., poly- arteritis nodosa) in which this type of necrosis is seen are described in Chapter 4. MECHANISMS OF CELL INJURY Now that we have discussed the causes of cell injury and the morphologic changes in necrosis, we next consider in more detail the molecular basis of cell injury, and then illustrate the important principles with a few selected examples of common types of injury. The biochemical mechanisms linking any given injury with the resulting cellular and tissue manifestations are complex, interconnected, and tightly interwoven with many intracellular metabolic pathways. Nevertheless, § Típica de reações imunes com imunocomplexos em combinação com fibrina na parede de vasos; § Aparência amorfa e róseo-‐brilhante, pela coloração de H&E. PATOLOGIA – Lesão e morte celular Necrose fibrinoide: Necrose fibrinoide na artéria. A parede da artéria mostra área circunferencial de necrose, rósea-‐brilhante, com inflamação (núcleos escuros dos neutrófilos). 18/03/20 6 Apoptose de / cair Mecanismo de morte celular no qual a célula degrada seu próprio DNA e suas próprias proteínas, de maneira ordenada e sem levar a inflamação. PATOLOGIA – Lesão e morte celular Conhecida como: “morte celular programada" Apoptose Eliminação de células não mais necessárias Eliminação de células indesejáveis ou potencialmente danosas ao organismo Apoptose: PATOLOGIA – Lesão e morte celular Fisiológica Patológica Apoptose: PATOLOGIA – Lesão e morte celular § Eliminar células que não são mais necessárias. § Manter um número constante das várias populações celulares nos tecidos. § Elimina células que são lesadas de modo irreparável, limitando a lesão tecidual paralela. • Desenvolvimento embrionário: • Involução de órgãos por privação hormonal: PATOLOGIA – Lesão e morte celular Apoptose fisiológica: • Perda celular em populações celulares proliferativas: • Eliminação de linfócitosautorreativos potencialmente nocivos: • Morte de células que já tenham cumprido seu papel: PATOLOGIA – Lesão e morte celular Apoptose patológica: § Lesão de DNA, § Acúmulo de proteínas anormalmente dobradas, § Infecções, § Atrofia patológica no parênquima de órgãos após obstrução de ducto. Apoptose: Aspectos morfológicos: § Diminuição do volume celular; § Fragmentação do núcleo; § Condensação da cromatina; § Projeções na membrana plasmática; § Formação de corpos apoptóticos; § Fagocitose. PATOLOGIA – Lesão e morte celular 19 A po pt os is of m ul tip le c on se rv ed d om ai ns o f th e Bc l-2 f am ily ). Th ey in t ur n ac tiv at e tw o pr o- ap op to tic m em be rs o f th e fa m ily ca lle d Ba x an d Ba k, w hi ch d im er iz e, in se rt in to t he m ito - ch on dr ia l m em br an e, a nd f or m c ha nn el s th ro ug h w hi ch cy to ch ro m e c an d ot he r m ito ch on dr ia l p ro te in s es ca pe in to th e cy to so l. Th es e se ns or s al so i nh ib it th e an ti- ap op to tic m ol ec ul es B cl -2 a nd B cl -x L (s ee fu rt he r on ), en ha nc in g th e le ak ag e of m ito ch on dr ia l p ro te in s. C yt oc hr om e c, to ge th er w ith s om e co fa ct or s, a ct iv at es c as pa se -9 . O th er p ro te in s th at le ak o ut o f m ito ch on dr ia b lo ck th e ac tiv iti es o f c as pa se an ta go ni st s th at fu nc tio n as p hy si ol og ic in hi bi to rs o f a po p- to si s. T he n et re su lt is th e ac tiv at io n of th e ca sp as e ca sc ad e, ul tim at el y le ad in g to n uc le ar fr ag m en ta tio n. C on ve rs el y, if ce lls a re e xp os ed t o gr ow th f ac to rs a nd o th er s ur vi va l si gn al s, t he y sy nt he si ze a nt i-a po pt ot ic m em be rs o f th e Bc l-2 f am ily , t he t w o m ai n on es o f w hi ch a re B cl -2 i ts el f an d Bc l-x L. Th es e pr ot ei ns a nt ag on iz e Ba x an d Ba k, a nd th us l im it th e es ca pe o f th e m ito ch on dr ia l pr o- ap op to tic pr ot ei ns . C el ls d ep ri ve d of g ro w th fa ct or s no t o nl y ac tiv at e th e pr o- ap op to tic B ax a nd B ak b ut a ls o sh ow r ed uc ed le ve ls o f Bc l-2 a nd B cl -x L, th us f ur th er t ilt in g th e ba la nc e to w ar d de at h. T he m ito ch on dr ia l p at hw ay s ee m s to b e th e pa th w ay t ha t is r es po ns ib le f or a po pt os is i n m os t si tu a- tio ns , a s w e di sc us s la te r. Th e D ea th R ec ep to r (E xt rin sic ) Pa th wa y of A po pt os is M an y ce lls e xp re ss s ur fa ce m ol ec ul es , c al le d de at h re ce p- to rs , t ha t tr ig ge r ap op to si s. M os t of t he se a re m em be rs o f th e tu m or n ec ro si s fa ct or ( TN F) r ec ep to r fa m ily , w hi ch co nt ai n in t he ir c yt op la sm ic r eg io ns a c on se rv ed “ de at h do m ai n, ” so n am ed b ec au se i t m ed ia te s in te ra ct io n w ith ot he r pr ot ei ns in vo lv ed in c el l d ea th . T he p ro to ty pi c de at h re ce pt or s ar e th e ty pe I TN F re ce pt or a nd F as (C D 95 ). Fa s lig an d (F as L) is a m em br an e pr ot ei n ex pr es se d m ai nl y on ac tiv at ed T l ym ph oc yt es . W he n th es e T ce lls r ec og ni ze Fa s- ex pr es si ng t ar ge ts , F as m ol ec ul es a re c ro ss -li nk ed b y Fa sL a nd b in d ad ap to r pr ot ei ns v ia t he d ea th d om ai n. Th es e in t ur n re cr ui t an d ac tiv at e ca sp as e- 8. I n m an y ce ll ty pe s ca sp as e- 8 m ay c le av e an d ac tiv at e a pr o- ap op to tic m em be r of t he B cl -2 f am ily c al le d Bi d, t hu s fe ed in g in to th e m ito ch on dr ia l pa th w ay . Th e co m bi ne d ac tiv at io n of bo th p at hw ay s de liv er s a le th al b lo w t o th e ce ll. C el lu la r pr ot ei ns , no ta bl y a ca sp as e an ta go ni st c al le d FL IP , bl oc k ac tiv at io n of c as pa se s do w ns tr ea m o f de at h re ce pt or s. In te re st in gl y, s om e vi ru se s pr od uc e ho m ol og ue s of F LI P, an d it is s ug ge st ed t ha t th is i s a m ec ha ni sm t ha t vi ru se s us e to ke ep in fe ct ed ce lls al iv e. Th e de at h re ce pt or pa th w ay is in vo lv ed in e lim in at io n of se lf- re ac tiv e ly m ph o- cy te s an d in k ill in g of t ar ge t ce lls b y so m e cy to to xi c T ly m ph oc yt es . Ac tiv at io n an d Fu nc tio n of C as pa se s Th e m ito ch on dr ia l a nd d ea th re ce pt or p at hw ay s l ea d to th e ac tiv at io n of th e in iti at or c as pa se s, c as pa se -9 a nd -8 , r es pe c- tiv el y. A ct iv e fo rm s of t he se e nz ym es a re p ro du ce d, a nd th es e cl ea ve a nd th er eb y ac tiv at e an ot he r s er ie s of c as pa se s th at a re c al le d th e ex ec ut io ne r ca sp as es . T he se a ct iv at ed c as - pa se s c le av e nu m er ou s t ar ge ts , c ul m in at in g in a ct iv at io n of nu cl ea se s th at d eg ra de D N A a nd n uc le op ro te in s. C as pa se s al so d eg ra de c om po ne nt s of t he n uc le ar m at ri x an d cy to - sk el et on , l ea di ng to fr ag m en ta tio n of c el ls . M ec ha ni sm s of A po pt os is A po pt os is r es ul ts fr om th e ac tiv at io n of e nz ym es c al le d ca sp as es (s o na m ed b ec au se th ey a re c ys te in e pr ot ea se s th at c le av e pr ot ei ns a ft er a sp ar tic r es id ue s) . T he a ct iv at io n of c as pa se s de pe nd s on a fi ne ly tu ne d ba la nc e be tw ee n pr od uc tio n of pr o- a nd a nt i-a po pt ot ic p ro te in s. T w o di st in ct p at hw ay s co nv er ge o n ca sp as e ac tiv at io n: t he m ito ch on dr ia l pa th w ay an d th e de at h re ce pt or p at hw ay ( Fi g. 1 –2 2) . A lth ou gh t he se pa th w ay s ca n in te rs ec t, th ey a re g en er al ly in du ce d un de r di ff er en t c on di tio ns , i nv ol ve d iff er en t m ol ec ul es , a nd se rv e di st in ct r ol es in p hy si ol og y an d di se as e. Th e M ito ch on dr ia l ( In tr in sic ) Pa th wa y of A po pt os is M ito ch on dr ia c on ta in s ev er al p ro te in s th at a re c ap ab le o f in du ci ng a po pt os is ; th es e pr ot ei ns i nc lu de c yt oc hr om e c an d ot he r p ro te in s t ha t n eu tr al iz e en do ge no us in hi bi to rs o f ap op to si s. T he c ho ic e be tw ee n ce ll su rv iv al a nd d ea th i s de te rm in ed b y th e pe rm ea bi lit y of m ito ch on dr ia , w hi ch is co nt ro lle d by a fa m ily o f m or e th an 2 0 pr ot ei ns , t he p ro to - ty pe o f w hich is B cl -2 (F ig . 1 –2 3) . W he n ce lls a re d ep ri ve d of g ro w th fa ct or s a nd o th er su rv iv al si gn al s, o r a re e xp os ed to a ge nt s th at d am ag e D N A , o r ac cu m ul at e un ac ce pt ab le am ou nt s of m is fo ld ed p ro te in s, a n um be r of s en so rs a re ac tiv at ed . T he se s en so rs a re m em be rs o f th e Bc l-2 f am ily ca lle d “B H 3 pr ot ei ns ” (b ec au se th ey c on ta in o nl y th e th ir d Fi gu re 1 –2 1 M or ph ol og ic a pp ea ra nc e of a po pt ot ic c el ls. A po pt ot ic ce lls (s om e in di ca te d by a rro w s) in a n or m al c ry pt in th e co lo ni c ep ith el iu m ar e sh ow n. (T he p re pa ra tiv e re gi m en fo r co lo no sc op y fre qu en tly in du ce s ap op to sis in e pi th el ia l c el ls, w hi ch e xp la in s th e ab un da nc e of d ea d ce lls in th is no rm al ti ss ue .) N ot e th e fr ag m en te d nu cl ei w ith c on de ns ed c hr o- m at in a nd t he s hr un ke n ce ll bo di es , s om e w ith p ie ce s fa llin g of f. (C ou rte sy o f D r. Sa nj ay K ak ar , D ep ar tm en t of P at ho lo gy , U ni ve rs ity o f C al ifo rn ia S an F ra nc isc o, Sa n Fr an cis co , C al if.) 18/03/20 7 Apoptose: Aspectos bioquímicos: PATOLOGIA – Lesão e morte celular § Ativação das Caspases. § Quebra do DNA e Proteína. § Alterações da Membrana e Reconhecimento pelos Fagócitos. Eletroforese de DNA A: células viáveis B: apoptose “escadas” C: necrose “difuso” Apoptose: Aspectos bioquímicos: PATOLOGIA – Lesão e morte celular Ativação das Caspases: § Caspase: enzima da família de cisteína proteases. • “c” = cisteína protease (enzima com cisteína no sítio ativo). • “aspase” = habilidade em clivar resíduos de ácido aspártico. § Funcionalmente dividida em dois grupos: • Desencadeador: caspase-‐2, -‐8, -‐9, -‐10. • Executor: caspase-‐3, -‐6, -‐7. § Pró-‐enzimas inativas (zimogênios): devem sofrer clivagem enzimática para tornarem-‐se ativas. § Caspases ativas (clivadas):marcador de células em apoptose. Apoptose: Mecanismos: PATOLOGIA – Lesão e morte celular Início da apoptose: por sinais originados de duas vias distintas: Fosfolipídios do folheto da membrana interno para o externo Apoptose: Distúrbios Associados à Apoptose Desregulada: PATOLOGIA – Lesão e morte celular § Distúrbios associados com apoptose defeituosa e aumento da sobrevida celular: • Permite a sobrevida de células anormais, com consequências. • Ex: -‐ câncer devido a mutações no gene p53. • -‐ pode ser a base dos distúrbios autoimunes. § Distúrbios associados com o aumento da apoptose e morte celular excessiva: • Doenças neurodegenerativas: perda de grupos específicos de neurônios, devido mutações e proteínas anormalmente dobradas. • Lesão isquêmica: infarto miocárdico e acidente vascular cerebral. • Morte de células infectadas por vírus: muitas infecções virais. Autofagia: PATOLOGIA – Lesão e morte celular § Processo no qual a célula digere seu próprio conteúdo. § Mecanismo de sobrevivência em períodos de privação de nutrientes, reciclando os conteúdos digeridos. Fagolisossomo PATOLOGIA – Lesão e morte celular Característica Necrose Apoptose Tamanho celular Aumentado (tumefação) Reduzido (retração) Núcleo Picnose, cariorrexe e cariólise Fragmentação em fragmentos do tamanho nucleossomas Membrana plasmática Rompida Intacta; estrutura alterada, especialmente a orientação dos lipídios Conteúdos celulares Digestão enzimática; podem extravasar da célula Intactos; podem ser liberados em corpos apoptóticos Inflamação adjacente Frequente Nenhuma Papel fisiológico ou patológico Invariavelmente patológico (finalização da lesão celular irreversível) Frequentemente fisiológico (eliminação de células indesejadas); pode ser patológica (após algumas formas de lesão, especialmente lesão de DNA).
Compartilhar